About Dr. Philip George
He has also been nominated for a Nobel Prize.
Dr. Philip George’s accomplishments were honored with inclusion in the 2007-2008 edition of the Heritage Registry of Who’s Who, a New York based biographical publication that selects distinguished individuals throughout North America who have attained a recognizable degree of success in their field of endeavor and thereby contributed to the growth of their industry. He has also been nominated for a Nobel Prize.
Philip George is the Director of Respiratory Care Services at Franklin Center for Rehabilitation and Nursing in Flushing, New York. He is known for pioneering a new nonsurgical procedure for decannulation (removing tracheotomy tubes) as well as for his asthma research.
He presented a scientific research paper on his method of tracheotomy tube removal to pulmonary and cardiology physicians and specialists from around the world at the American Thoracic Society (ATS) international conference in Seattle, Washington. The paper was titled “Disposition and Outcome of Tracheotomy Patients Enrolled in Decannulation Protocol.”
Philip George has also conducted double-blind studies on the effects of nutritional supplements for a variety of patients. He has presented papers at international conferences in multiple countries on his research studies about the effects of dairy products on bronchial asthma and the effects of Vitamin B-complex injections for ALS patients. He has been awarded an honorary Ph.D. in recognition of his research efforts.
Dr. Philip George’s research into the effects of specific vitamins on a variety of diseases has led him to develop of Renervee, a vitamin tablet formulated to benefit patients with incurable diseases.
